Jymed tekinoroji co.
Kugadzirwa kwakawanda nemhando yakagadzikana
Sekureva kwaJymed tekinoroji manejimendi, iyo bulk kugadzirwa kweTirzepatide inoshanda pharmaceuticuical chipsarudzo (API) inogona kusvika kilograph levels. Iyo yekugadzira mabheji yakagadzikana uye inoenderera, ine kusiyana-kusiyanisa pakati pebhatsi, kuve nechokwadi chinosanganisira.
Yakakosha mhedzisiro pane glucose uye lipid kuderedzwa
Tirzepatide ndiyo yenyika yekutanga kubvumidzwa kamwe-vhiki yeGIP / GLP-1 Receptor Agonist. Semunhu anogamuchira agonist aronist, anogona kujairika kusunga uye activate ese ari maviri eglucose-anotsamira insulinotropic polypeptide (gip) regreptor uye iyo GLP-1 Receptor mumuviri wemunhu. Kuwedzera pakudzikisa glucose mazinga, inoderedza kudya kwekudya, uremu hwemuviri, uye zviyero zvakakura, uye zvigadziriso LIPID kushandiswa. Kupfuura kwayo kwakakura kweGlucose-kuderedza uye kurema kuongorora kubva pane zvakapfuura zvidzidzo zvakaratidza kuti neropa zvakadai sekumanikidzwa kweropa, lipsi dzeropa, BMI, uye chiuno tenderme.
Mitemo yemarudzi mazhinji uye inosimudzira tarisiro
Sekureva kweruzivo rwakakodzera, iyo Glucose-yakadzika mounjaro yakatanga kutenderwa neUS FDA muna Chivabvu 2022 yekubatwa kwevakuru neryirini 2 chirwere cheshuga. Iyo yakazotambira yakagashira mabvumirano muEU, Japan, nedzimwe matunhu. MunaNovember 2023, FDA zvakare akatendera zvakare kureruka uremu chiratidzo pasi pezita zita rekuti Zepbound. Muna May 2024, yakabudirira kupinda mumusika weChinese. Kupiwa kwaro kwakakura kushandisa tarisiro uye kutsigira kwakasimba data rekutsvaga, tirzepatide yave imwe yemishonga yakakurumbira yePeptide nhasi. Kutengesa kwayo kwasvika madhora mazana mashanu.163 bhiriyoni muna 2023, uye chikamu chekutanga che2024 chete chakawonekwa che $ 2.32422 bhiriyoni, kuratidza huwandu hwekuwedzera kwekuwedzera.
About JyMed
Shenezhen Jymed tekinoroji Co, Ltd. (Hezeyafter anonzi Jymed) akagadzwa muna 2009, hunyanzvi hwekutsvagisa, kugadzirwa, uye zvigadzirwa zvine chekuita nezvinhu zvine chekuita nePeptide. Neimwe nzvimbo yekutsvagisa uye matatu makuru ekugadzira zvigadziko, jymed ndeimwe yevakakura vanogadzira yemakemikari synthesised peptide apis muChina. Iyo kambani yekambani r & d timu inozvirumbidza pamusoro pemakore makumi maviri ezvakaitika mune yePeptide indasitiri uye yakabudirira kupfuudza fda yekuongorora kaviri. Jymed's yakazara petside peide Industrialation system inopa vatengi yakazara huwandu hwemasevhisi, veteriness peptides, antimicrobial mappides, uye pamwe nekunyoresa uye yekuzvidzivirira.
Zviitiko zvikuru zvebhizinesi
1.mestic uye International Kunyoresa yePeptide Apis
2.Venerani uye cosmetic mappides
3.cSTTTTTHE PEPIDS uye CLO, CMO, OEM SEASES
4.PDC Zvinodhaka (Peptide-Radionuclide, Peptide-diki Molecule, Peptide-Protein, Peptide-rna)
Pamusoro peTirzepatide, Jymed akaendesa maFiles neFDA uye CDE yeimwezve API Zvigadzirwa, kusanganisira iyo ino inozivikanwa GLP mishonga yeGLP yakadai seyakawa semaglaride uye liraglaride. Vatengi vemunguva yemberi vachishandisa zvigadzirwa zveJymed vanokwanisa kutaura zvakananga iyo cde yekunyoresa nhamba kana DMF faira nhamba kana kutumira kunyoresa kunyoreswa kune fda kana cde. Izvi zvichaderedza zvakanyanya nguva inodiwa pakugadzirira zvinyorwa zvinyorwa, pamwe nenguva yekuongorora uye mutengo wekuongorora chigadzirwa.
Taura nesu
Shenezhen Jymed Technology Co, Ltd.
Kero:8th & 9th floors, chivakwa 1, shenzhhen biemidical gadziridzo yeindasitiriPark, Nha. 14 Jinda Road, Kengei Mugwagwa, Pingshan Dunhu, Shenzhen
Runhare:+8 7555512112
Webhusaiti: http://www.jymedech.com/
Kutumira Nguva: Aug-12-2020
